Antituberculosis activity of clarithromycin
- 1 December 1995
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (12) , 2692-2695
- https://doi.org/10.1128/aac.39.12.2692
Abstract
Antituberculosis activity of clarithromycin (CLA), a macrolide antibiotic, was investigated in vitro, in macrophages, and in C57BL/6 mice, CLA showed high in vitro MICs (4 to > 16 micrograms/ml) for several strains of Mycobacterium tuberculosis and caused slight enhancement of activity of rifampin (RIF) against H37Rv but failed to increase the activity of either RIF or isoniazid (INH) against other strains. However, inside J774A.1 macrophages, CLA showed high activity and was synergistic with RIF against some strains of tubercle bacilli susceptible or resistant to INH and RIF. In the in vivo studies with a drug-susceptible strain (H37Rv), CLA protected mice from mortality due to tuberculosis for up to 8 weeks of observation. The CFU data for lungs and spleens revealed that the antituberculosis activity of CLA is inferior to those of INH and streptomycin. However, the activity of CLA when used alone or in combination was comparable to that of thiacetazone, indicating its potential usefulness as a secondary drug for the treatment of tuberculosis.Keywords
This publication has 13 references indexed in Scilit:
- Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1995
- Enhancement of drug susceptibility of multi-drug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulphoxideJournal of Antimicrobial Chemotherapy, 1995
- Rapid assessment of mycobacterial growth inside macrophages and mice, using the radiometric (BACTEC) methodTubercle and Lung Disease, 1994
- Penetration of clarithromycin into lung tissues from patients undergoing lung resectionAntimicrobial Agents and Chemotherapy, 1994
- Activity of Clarithromycin againstMycobacterium aviumInfection in Patients with the Acquired Immune Deficiency Syndrome: A Controlled Clinical TrialAmerican Review of Respiratory Disease, 1991
- Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1991
- In vitro and in vivo activities of clarithromycin against Mycobacterium aviumAntimicrobial Agents and Chemotherapy, 1989
- New directions for macrolide antibiotics: pharmacokinetics and clinical efficacyAntimicrobial Agents and Chemotherapy, 1989
- Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycinAntimicrobial Agents and Chemotherapy, 1989
- Synergistic effects of antimycobacterial drag combinations onMycobacterium avium complex determined radiometrically in liquid mediumEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987